FTDC criteria* for possible FTD

Slides:



Advertisements
Similar presentations
The Memory Assessment and Treatment Service (MATS)
Advertisements

Management of Early Dementia Dr Eleanor Mullan Consultant Psychiatrist Mental Health Services for Older People South Lee, Cork Feb 2011.
Frontotemporal Dementia
John O’Brien Institute for Ageing and Health Newcastle University and Northumberland, Tyne and Wear NHS Trust Making the diagnosis well: experience from.
Screening By building screening for symptoms of VCI into regular workflows or practice, health care providers are participating in Taking Action to address.
Dementia with Lewy Bodies
Generalized Neurodegenerative dementias AD Dementia with Lewy Bodies (DLB) Mixed Frontotemporal Lobar Degeneration (FTLD) Others.
GAL-INT-6 The safety and efficacy of galantamine in patients with Vascular dementia or AD with cerebrovascular disease Sean Lilienfeld MD, FCP, MMed Janssen.
Dementia. Definition Loss of function in multiple cognitive abilities Assuming the individual had normal abilities before the onset Many of the 70 recognized.
How Alzheimer’s Disease Differs from Frontal Temporal Lobe Dementia (Pick’s Disease) Josepha A. Cheong, MD University of Florida Departments of Psychiatry.
A 67-year-old male with behavioral and language problems
Supporting Employees with Early Onset Dementias & other cognitive deficits Dr Miriam Prins Consultant Clinical Neuropsychologist Head of Older Adults Psychology.
Nice guidelines Definition  Widespread deterioration in cerebral function without impairment of consciousness.  Occurs across a widespread of.
Subtype of VaD: SIVD Subcortical Ischemic Vascular Disease Helena Chui, M.D. University of Southern California Rancho Los Amigos National Rehabilitation.
Screening for Stroke and Cognitive Impairment Chapter 2: Background.
Alzheimer’s Assessment Assessing the Cognitive-Linguistic effects of Alzheimer’s.
ALZHEIMER’S DISEASE BY OLUFOLAKUNMI KEHINDE PRE-MD 1.
Dementia in Clinical Practice Mary Ann Forciea MD Clinical Prof of Medicine Division of Geriatric Medicine UPHS Photo: Nat Geographic.
Non-Alzheimer’s Dementias
2010 MEETING, PHILADELPHIA AMERICAN ASSOCIATION OF NEUROPATHOLOGISTS DSS CASE # 11 J-M BILBAO, B YOUNG and N LIU SUNNYBROOK HOSPITAL UNIVERSITY OF TORONTO.
 Alzheimer's disease (AD), also known as Senile Dementia of the Alzheimer Type (SDAT) or simply Alzheimer’s is the most common form of dementia. This.
Dementia. What is Dementia? Dementia is a gradual decline of mental ability that affects your intellectual and social skills to the point where daily.
Dementia 痴呆 Jie Ming Shen, M.D., Ph.D. Department of Neurology Ruijin Hospital, SSMU.
Are spatial tasks useful for the early diagnosis of Alzheimer’s disease.
HOW TO EXAMINE PATIENTS WITH DEMENTIA Serge Gauthier, MD, FRCPC McGill Centre for Studies in Aging Douglas Mental Health Research Institute.
The Dementias Dr Giles Richards Consultant Psychiatrist CFT.
Non Alzheimer's Dementias Elizabeth Landsverk, MD Geriatrician, ElderConsult Geriatric Medicine Adjunct Professor of Medicine, Stanford University.
DEMENTIA ABDULMAJEED ALOLAYAH What is DEMENTIA ? It is a chronic global impairment of cognitive functions without disturbed consciousness.
Dementia: Alzheimer’s Disease Cyril Evbuomwan Patient Group Meeting 1 st December 2015.
Dementia Nicholas Cascone, PA-C.
Mariano Musacchio 1 François Sellal 2 Frédéric Blanc 2 Jean-Marc Michel 2 Stephan Kremer 3 Jean-Louis Dietemann 3 1 Department of Neuroradiology - CHG.
Seniors with Memory Loss: A Primer Praveen Dayalu, MD Clinical Associate Professor Department of Neurology University of Michigan.
Types of Dementia Dr Bernie Coope Associate Medical Director/Honorary Senior Lecturer, Worcester University Association for Dementia Studies.
Delusional misidentification syndromes (DMS) are a group of rare and varied disorders in which, in their typical form, the patient thinks that a particular.
Frontotemporal Lobar Degeneration:
DEGENERATIVE DISEASES is a disease in which the function or structure of the affected tissues or organs will progressively deteriorate over time, whether.
DEMENTIA 1/6/16 DR TONY O’BRIEN MD FRCP. Dementia Common – 700,000 sufferers in the UK Common – 700,000 sufferers in the UK Prevalence increases with.
Dementia – everything you need to know but were afraid to ask
The Malfunctioning Mind: Degenerative Diseases of the Brain
Investigating dementia
Value of cerebrospinal fluid visinin-like protein-1 (VILIP-1) for prediction of mild cognitive impairment progression to Alzheimer's disease  Mirjana Babić.
The Malfunctioning Mind: Degenerative Diseases of the Brain
Dementia Jaqueline Raetz, M.D..
Radiological imaging of dementia.
DEMENTIA Shenae Whitfield & Kate Maddock.
Vascular Dementia Lewis and Escalin.
Use of Amyloid PET Scan in Early Diagnosis of Alzheimer’s Disease in a Secondary Care Memory Clinic Niki Schoonenboom, MD PhD1, Mohammed Akarriou, MD2;
A Sporadic Case of Progressive Non-Fluent Aphasia
Brain Anatomy and Function
Dementia: from molecules to minds
Unit 40 Dementia care.
Cognitive screening tests: Montreal Cognitive Assessment (MoCA)
Dementia Jaqueline Raetz, M.D..
Fig. 11. Algorithm for differential diagnosis of cognitive impaired subjects by employing structural imaging. AD = Alzheimer's disease, BG = basal ganglia,
Neuroimaging findings in patients with cerebral organic acid disorders
Neuroimaging findings in patients with cerebral organic acid disorders
Dementia Care Jagruti Rehabilitation Centre. Introduction  Dementia is not a single illness but a group of symptoms caused by damage to the brain. The.
Presenter : Dr Aneelraj Co investigators : Dr Srikala Bharath
Imaging AD Progression Amyloid Imaging Agents.
Brain Tech TIME Case Study: FDG PET IMAGING IN DEMENTIA (FTD vs AD)
Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy (CADASIL) and Review of Literature Zebin Xiao Department of.
First they said she had schizophrenia and now she cant remember
Nat. Rev. Neurol. doi: /nrneurol
Coronal (above) and axial (below) views of brain imaging findings in selected young onset dementias (images reproduced by kind permission of Dr Hadi Manji.
Chapter 30 Delirium and Dementia
Dementia and TBI.
Chapter 93 Dementias and Related Disorders
Neuropathology of epilepsy: epilepsy-related deaths and SUDEP
The Memory Assessment and Treatment Service (MATS)
Presentation transcript:

FTDC criteria* for possible FTD Pure vascular dementia mimicking the behavioural variant of frontotemporal lobar degeneration : about 3 autopsied cases V. Deramecourt1, 2, 3, F. Lebert1, 2, C.A. Maurage1, 3, 4, F. Pasquier1, 2 1 Univ. Lille Nord de France, EA1046, UDSL, Lille, France 2 Lille University Hospital, Memory Clinic, French national reference centre for young onset Alzheimer patients, Lille, France 3 Univ. Lille Nord de France, Histology department, UDSL, Lille, France 4 Lille University Hospital, Pathology Department, Functional unit of Neuropathology, Lille, France INTRODUCTION Early behavioral disinhibition, apathy, loss of empathy, perseverative behavior, dietary changes and decline in executive tasks are core features of the behavioral variant of frontotemporal lobar degeneration (bvFTD). Recent reports have highlighted atypical cases (phenocopy cases) characterized by a long lasting, very slowly or non progressive presentation of bvFTD but neuropathological data are usually unavailable. Case n°1 Case n°2 Case n°3 gender male female Age at onset (y) 59 52 60 Duration of the disease (y) 17 3 5 Past medical history hypertension Hypertension Type 2 diabetes hypercholesterolemia Family history of dementia no « Frontal » dementia in her grandmother, her mother (aged 55 at onset) and uncle. FTDC criteria* for possible FTD yes Early behavioural disinhibition Socially inappropriate behaviour  (public urination, exhibitionism)  (rudeness, aggressiveness)  Loss of manner or decorum  (self neglect) Impulsive, rash or careless actions Early apathy or inertia apathy  severe, at foreground inertia  (pseudo catatonia) Early loss of sympathy or empathy Diminished responses to other people’s needs or feeling  (absence of emotion) Diminished social interest , interrelatedness or personal warmth Early perseverative stereotyped or compulsive ritualistic behaviour Simple repetitive movements  (scratching) Complex compulsive or ritualistic movements  (dressing/undressing)  (walking) (shaving) Stereotypy of speech  : « I’m screwed» : « that’s all »,«I don’t know » Hyperorality and dietary changes Altered food preference Binge eating, increased consumption of alcohol or cigarettes Oral exploration or consumption of inedible objects Neuropsychological profile Global cognition scores (MMSE/30 ; Mattis DRS/144) First : 28 ; 127 Last : 29 ; 128 First: 18 ; not done first: 28 ; 126 Decline in executive tasks Relative sparing of episodic memory Not applicable Relative sparing of visuospatial skills Functional decline No Other clinical features Gait impairment Mild left akinesia Rapid onset : catatonia Anxiety, akathisia. Perseverative ideas (about his tongue and teeth), agitation, Phobia about water Psychomotor instability treatments Serotonin recapture inhibitor Benzodiazepines, neuroleptics No psychoactive drug MRI data Periventricular leukoaraiosis, left lenticular lacune. Mild global atrophy. Left external capsule lacune Mild punctiform leukoaraiosis No atrophy Left caudate lacunar infarct. Small cerebellar infarct. Global atrophy. SPECT data normal Bilateral temporoparietal hypoperfusion Left frontotemporal hypoperfusion. CSF biomarkers data Not done Isolated low Ab-42 Cause of death Acute stroke, aspiration pneumonia Aspiration pneumonia Post mortem brain neuropathology Mild atrophy (brain weight=1400g) Multiple lacunes (hemispheric white matter, basal ganglia, pons, cerebellum), leukoaraiosis. Arteriolosclerosis No evidence of FTLD. Mild atrophy (brain weight=1350g) Multiple lacunes within the basal ganglia and hemispheric white matter Calcified arteriolosclerosis Numerous corpora amylacea Mild global atrophy (brain weight=1200g) No evidence of FTLD Diffuse arteriolosclerosis Microlacunes within the putamen, thalamus, temporal and frontal white matter. METHODS three case reports with a pathologically proven diagnosis of pure vascular dementia who presented with severe behavioral core features of bvFTD. these cases were investigated in the Lille University Hospital memory clinic: longitudinal follow-up with neurological, neuropsychological and behavioural evaluations. All cases had brain MRI and HMPAo SPECT Only one had a CSF sampling for Alzheimer’s biomarkers. Neuropathological assessment on the left hemisphere (the right one was frozen at -80°C). All cases were investigated with Tau, TDP-43, Ubiquitin, neurofilament, a-synuclein, Ab and PrP immunohistochemistry. Two large sections at the level of the mamillary body and pons were stained with H&E and Kluver-Barrera. RESULTS the 3 cases fulfilled the FTDC criteria for possible behavioural FTD* one of them had long lasting, non progressive variant (FTD phenocopy), the two others had  a rapid progression of 3 and 5 years from onset to death. They all lacked anterior atrophy and hypometabolism consistent with behavioural FTD Brain MRI only showed mild evidence for vascular pathology despite the final neuropathological diagnosis. FTLD pathology was excluded in each case. Microscopic examination showed prominent sub cortical chronic ischemic changes caused by arteriolosclerosis. Mild atrophy in case 2. Scattered white matter discoloration. Calcified arteriolosclerosis, perivascular space dilatation and microlacunes in case 2. (pallidum, H&E staining) « état criblé » of the putamen in case 3 (H&E staining) Mild atrophy in case 3, no macroscopic visible vascular lesion. CONCLUSIONS Isolated subcortical microvascular pathology may underlie atypical presentation of bvFTD including the long lasting, non-progressive variant. These observations also support the revised diagnosis criteria for bvFTD (international bvFTD criteria consortium) which require both functional decline and imaging results consistent with bvFTD to meet criteria for a probable diagnosis. REFERENCES * Rascovsky et al, Brain 2011, in press. (http://memory.ucsf.edu/ftd/medical/diagnosis/criteria/multiple/bvftd)